Amanote Research
Register
Sign In
Correction: Synergistic Interaction Between the HDAC Inhibitor, MPT0E028, and Sorafenib in Liver Cancer CellsIn VitroandIn Vivo
Clinical Cancer Research
- United States
doi 10.1158/1078-0432.ccr-18-1455
Full Text
Open PDF
Abstract
Available in
full text
Categories
Cancer Research
Oncology
Date
July 1, 2018
Authors
Unknown
Publisher
American Association for Cancer Research (AACR)
Related search
Synergistic Inhibition of Angiogenesis by Artesunate and CaptoprilIn VitroandIn Vivo
Evidence-based Complementary and Alternative Medicine
Alternative Medicine
Complementary
Synergistic Cytotoxic Effect of the Microtubule Inhibitor Marchantin a fromMarchantia Polymorphaand the Aurora Kinase Inhibitor MLN8237 on Breast Cancer CellsIn Vitro
Planta Medica
Organic Chemistry
Molecular Medicine
Pharmacology
Complementary
Pharmaceutical Science
Analytical Chemistry
Alternative Medicine
Drug Discovery
Synergistic Antitumour Activity of HDAC Inhibitor SAHA and EGFR Inhibitor Gefitinib in Head and Neck Cancer: A Key Role for ΔNp63α
British Journal of Cancer
Cancer Research
Oncology
Kinase Inhibitor Sorafenib Modulates Immunosuppressive Cell Populations in a Murine Liver Cancer Model
Laboratory Investigation
Forensic Medicine
Pathology
Cell Biology
Molecular Biology
Synergistic Antitumor Effects of Novel HDAC Inhibitors and Paclitaxel in Vitro and in Vivo
PLoS ONE
Multidisciplinary
Knockdown of Caveolin-1 by siRNA Inhibits the Transformation of Mouse Hepatoma H22 CellsIn VitroandIn Vivo
Oligonucleotides
Author Correction: Interaction Between the Microbiome and TP53 in Human Lung Cancer
Genome Biology
The HSP90 Inhibitor Onalespib Exerts Synergistic Anti-Cancer Effects When Combined With Radiotherapy: An in Vitro and in Vivo Approach
Scientific Reports
Multidisciplinary
A Small-Molecule Inhibitor of BCL-XLPotentiates the Activity of Cytotoxic DrugsIn vitroandIn Vivo
Cancer Research
Cancer Research
Oncology
